Works matching T lymphocytes


Results: 5000
    1
    2
    3
    4
    5
    6

    Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.

    Published in:
    Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 639, doi. 10.1007/s00262-012-1366-6
    By:
    • Nobuoka, Daisuke;
    • Yoshikawa, Toshiaki;
    • Takahashi, Mari;
    • Iwama, Tatsuaki;
    • Horie, Kazutaka;
    • Shimomura, Manami;
    • Suzuki, Shiro;
    • Sakemura, Noriko;
    • Nakatsugawa, Munehide;
    • Sadamori, Hiroshi;
    • Yagi, Takahito;
    • Fujiwara, Toshiyoshi;
    • Nakatsura, Tetsuya
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma.

    Published in:
    British Journal of Dermatology, 2025, v. 192, p. 316, doi. 10.1093/bjd/ljae401
    By:
    • McGillivray, Erin;
    • Ashouri, Karam;
    • Chatziioannou, Eftychia;
    • Gallegos, Jesús Antonio Ocejo;
    • Zarka, Jabra;
    • Kechter, Jacob;
    • Hwang, Angelina S;
    • Zhang, Kevin;
    • Barros, Milton;
    • Yeh, Justin;
    • Okazaki, Ian;
    • Crocker, Andrew B;
    • Maeda, Takuya;
    • Park, Soo J;
    • Choi, Jacob;
    • Andreoli, Mia;
    • Darwish, Tarneem;
    • Savage, David J;
    • Kim, Kevin B;
    • Gupta, Jayant
    Publication type:
    Article
    27
    28
    29

    Development of New Monoclonal Antibodies against Cytotoxic T-Lymphocyte Antigen-4.

    Published in:
    Crystallography Reports, 2024, v. 69, p. S38, doi. 10.1134/S1063774524602892
    By:
    • Demyanov, A. V.;
    • Garaeva, L. A.;
    • Sergeeva, E. V.;
    • Nikitina, A. V.;
    • Putevich, E. D.;
    • Emelianova, S. S.;
    • Spitsyna, A. S.;
    • Solomina, L. A.;
    • Potyseva, A. S.;
    • Volnitskij, A. V.;
    • Solianik, A. M.;
    • Sidorova, Zh. Yu.;
    • Zhahov, A. V.;
    • Burdakov, V. S.;
    • Verlov, N. A.;
    • Kvanchiani, V. V.;
    • Konevega, A. L.;
    • Shtam, T. A.
    Publication type:
    Article
    30
    31
    32
    33
    34

    Cytotoxic T lymphocyte antigen‐4 regulates development of xenogenic graft versus host disease in mice via modulation of host immune responses induced by changes in human T cell engraftment and gene expression.

    Published in:
    Clinical & Experimental Immunology, 2021, v. 206, n. 3, p. 422, doi. 10.1111/cei.13659
    By:
    • Gao, Chunxu;
    • Gardner, Debra;
    • Theobalds, Marie‐Clare;
    • Hitchcock, Shannon;
    • Deutsch, Heather;
    • Amuzie, Chidozie;
    • Cesaroni, Matteo;
    • Sargsyan, Davit;
    • Rao, Tadimeti S.;
    • Malaviya, Ravi
    Publication type:
    Article
    35
    36
    37
    38
    40
    41
    42
    43

    A randomized, double-blind, and placebo-controlled multicenter clinical trial of a novel cytotoxic T-lymphocyte antigen-4 fusion protein, Leining, in Chinese active rheumatoid arthritis patients with an inadequate response to methotrexate.

    Published in:
    Rheumatology International, 2014, v. 34, n. 11, p. 1519, doi. 10.1007/s00296-014-2989-z
    By:
    • Fan, Wei;
    • Zhao, Dong-bao;
    • Hu, Shao-Xian;
    • Xu, Hu-ji;
    • Zhang, Xiao;
    • Zhang, Miu-jia;
    • Chen, Zhi-wei;
    • Zhang, Feng-xiao;
    • Zhu, Ping;
    • Li, Xin-fu;
    • Bi, Li-qi;
    • Zhou, Bin;
    • Bao, Chun-de
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50